Related Experiment Video
Updated: May 2, 2026
05:30
Trophoblast Cell Recovery from Angiogenesis-Tube Formation Assay for Differentiation Marker Expression Analysis
Published on: November 8, 2024
1.0K
Validation of histological diagnostic methods for detecting endothelin B receptor expression
Naoya Fukuda1, Takahiro Tsuchikawa1, Akira Fukunaga1
1Department of Gastroenterological Surgery II, Hokkaido University Graduate School of Medicine, Sapporo, Japan.
Oncology Reports
|February 20, 2014
Summary
This study aimed to optimize immunohistochemistry (IHC) for endothelin B receptor (ETBR) in pancreatic cancer. Results showed challenges in detecting ETBR in PDAC tissues, highlighting the need for proper controls.
Area of Science:
- Oncology
- Immunology
- Biochemistry
Background:
- Pancreatic ductal adenocarcinoma (PDAC) exhibits a poor prognosis.
- Tumor endothelial cell endothelin B receptor (ETBR) may impede antitumor immunity.
- Standardized immunohistochemistry (IHC) for ETBR is currently lacking.
Purpose of the Study:
- To establish optimal IHC conditions for detecting ETBR.
- To evaluate ETBR expression in human PDAC tissues.
- To validate ETBR detection using specific antibodies and controls.
Main Methods:
- Development of an ETBR-expressing cell line as a positive control.
- Testing multiple anti-ETBR antibodies for ETBR detection.
- Analysis of ETBR mRNA expression.
- IHC analysis of ETBR in human PDAC and normal tissues.
Main Results:
- Four anti-ETBR antibodies successfully detected cell surface ETBR.
- Non-specific reactions were observed in normal human tissues.
- Weak ETBR mRNA expression was detected only in the adrenal gland.
- No significant correlation was found in ETBR-IHC of PDAC sections.
Conclusions:
- Appropriate controls are essential for accurate IHC assessment of ETBR expression.
- Current IHC methods may face challenges in detecting ETBR in PDAC.
- Further research is needed to clarify ETBR's role in PDAC immunity.
